Published in Cell Mol Life Sci on July 01, 2000
Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev (2008) 2.64
Structure-based view of epidermal growth factor receptor regulation. Annu Rev Biophys (2008) 1.97
High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507). PLoS One (2009) 1.93
The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc Natl Acad Sci U S A (2004) 1.89
Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway. Oncogene (2010) 1.70
Role of insulin-like growth factor 1 receptor signalling in cancer. Br J Cancer (2005) 1.64
A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty. Clin Endocrinol (Oxf) (2002) 1.54
The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity. Proc Natl Acad Sci U S A (2006) 1.52
Higher-Resolution Structure of the Human Insulin Receptor Ectodomain: Multi-Modal Inclusion of the Insert Domain. Structure (2016) 1.48
Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J Immunol (2008) 1.45
Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases? Pharmacol Rev (2010) 1.39
Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer. J Clin Oncol (2010) 1.38
A metabolic signature of long life in Caenorhabditis elegans. BMC Biol (2010) 1.36
Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells. Cancer Res (2010) 1.36
Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth. Mol Biol Cell (2005) 1.36
Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation. Mol Syst Biol (2009) 1.33
Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Endocrinology (2007) 1.32
The role of IGF-1R in pediatric malignancies. Oncologist (2009) 1.27
Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts. Mol Cell Biol (2002) 1.27
Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis. Mol Carcinog (2010) 1.12
Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor. Oncogene (2011) 1.09
Cixutumumab. Expert Opin Investig Drugs (2009) 1.09
Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation. Cell Mol Life Sci (2013) 1.08
Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor. EMBO J (2008) 1.07
Two insulin-like peptides antagonistically regulate aversive olfactory learning in C. elegans. Neuron (2013) 1.04
Ca2+ channels in retinal pigment epithelial cells regulate vascular endothelial growth factor secretion rates in health and disease. Mol Vis (2007) 1.04
Insulin-like growth factor I controls adhesion strength mediated by alpha5beta1 integrins in motile carcinoma cells. Mol Biol Cell (2004) 1.04
Update in new anabolic therapies for osteoporosis. J Clin Endocrinol Metab (2010) 1.03
A comparative structural bioinformatics analysis of the insulin receptor family ectodomain based on phylogenetic information. PLoS One (2008) 1.02
Neuraminidase-1, a subunit of the cell surface elastin receptor, desialylates and functionally inactivates adjacent receptors interacting with the mitogenic growth factors PDGF-BB and IGF-2. Am J Pathol (2008) 0.99
Role of IGF-1 receptor in radiation response. Transl Oncol (2012) 0.97
Changes in the molecular phenotype of nucleus pulposus cells with intervertebral disc aging. PLoS One (2012) 0.96
Circulating tumor cell identification by functionalized silver-gold nanorods with multicolor, super-enhanced SERS and photothermal resonances. Sci Rep (2014) 0.96
Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors. Nat Clin Pract Oncol (2009) 0.96
Lipid rafts and caveolae in signaling by growth factor receptors. Open Biochem J (2007) 0.96
Integrin expression regulates neuroblastoma attachment and migration. Neoplasia (2004) 0.96
Serum response factor regulates bone formation via IGF-1 and Runx2 signals. J Bone Miner Res (2012) 0.95
Structural and biological properties of the Drosophila insulin-like peptide 5 show evolutionary conservation. J Biol Chem (2010) 0.94
Precise mapping of an IGF-I-binding site on the IGF-1R. Biochem J (2007) 0.94
Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I. J Biol Chem (2008) 0.94
A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma. J Hepatol (2013) 0.93
The three dimensional structure of the type I insulin-like growth factor receptor. Mol Pathol (2001) 0.92
Insulin-like growth factor-1 activates Akt and Jun N-terminal kinases (JNKs) in promoting the survival of T lymphocytes. Immunology (2002) 0.92
IGF-I signaling is essential for FSH stimulation of AKT and steroidogenic genes in granulosa cells. Mol Endocrinol (2013) 0.92
Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo. J Biol Chem (2009) 0.91
IGF-I receptor, cell-cell adhesion, tumour development and progression. J Mol Histol (2004) 0.90
Public and private mechanisms of life extension in Caenorhabditis elegans. Mol Genet Genomics (2007) 0.89
IGF-1 Receptor Differentially Regulates Spontaneous and Evoked Transmission via Mitochondria at Hippocampal Synapses. Neuron (2016) 0.88
Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy. Future Oncol (2012) 0.88
In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment. Tissue Eng Part B Rev (2013) 0.87
Mechanisms of activation of receptor tyrosine kinases: monomers or dimers. Cells (2014) 0.86
Insulin growth factor 1 receptor/PI3K/AKT survival pathway in outer segment membranes of rod photoreceptors. Invest Ophthalmol Vis Sci (2008) 0.86
Landmarks in insulin research. Front Endocrinol (Lausanne) (2011) 0.86
Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells. J Biol Chem (2010) 0.86
The relationship between the L1 and L2 domains of the insulin and epidermal growth factor receptors and leucine-rich repeat modules. BMC Bioinformatics (2001) 0.86
Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves' disease immunoglobins. J Clin Endocrinol Metab (2014) 0.85
Autoinhibition of the insulin-like growth factor I receptor by the juxtamembrane region. FEBS Lett (2007) 0.84
Structural basis of the aberrant receptor binding properties of hagfish and lamprey insulins. Biochemistry (2009) 0.84
Prostaglandin F2alpha represses IGF-I-stimulated IRS1/phosphatidylinositol-3-kinase/AKT signaling in the corpus luteum: role of ERK and P70 ribosomal S6 kinase. Mol Endocrinol (2010) 0.84
Targeting for insulin-like growth factor-I receptor with short hairpin RNA for human digestive/gastrointestinal cancers. J Gastroenterol (2009) 0.84
Effect of blocking IGF-I receptor on growth of human hepatocellular carcinoma cells. World J Gastroenterol (2006) 0.84
Hormone-triggered conformational changes within the insulin-receptor ectodomain: requirement for transmembrane anchors. Biochem J (2001) 0.83
Insulin-like growth factor-I-forkhead box O transcription factor 3a counteracts high glucose/tumor necrosis factor-α-mediated neuronal damage: implications for human immunodeficiency virus encephalitis. J Neurosci Res (2010) 0.83
Epitope-specific mechanisms of IGF1R inhibition by ganitumab. PLoS One (2013) 0.82
N-linked glycosylation supports cross-talk between receptor tyrosine kinases and androgen receptor. PLoS One (2013) 0.82
A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II. J Biol Chem (2009) 0.82
Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy. Cancer Metastasis Rev (2014) 0.82
Critical signal transduction pathways in CLL. Adv Exp Med Biol (2013) 0.81
Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications. J Biol Chem (2009) 0.81
Molecular targeted therapy in advanced renal cell carcinoma: A review of its recent past and a glimpse into the near future. Indian J Urol (2009) 0.81
Insulin: a small protein with a long journey. Protein Cell (2010) 0.81
Evaluation of a novel hexavalent humanized anti-IGF-1R antibody and its bivalent parental IgG in diverse cancer cell lines. PLoS One (2012) 0.81
Identifying molecular phenotype of nucleus pulposus cells in human intervertebral disc with aging and degeneration. J Orthop Res (2016) 0.81
IGF-1 release kinetics from chitosan microparticles fabricated using environmentally benign conditions. Mater Sci Eng C Mater Biol Appl (2014) 0.81
Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17. PLoS One (2012) 0.81
Transthyretin Induces Insulin-like Growth Factor I Nuclear Translocation Regulating Its Levels in the Hippocampus. Mol Neurobiol (2014) 0.80
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis. Int J Clin Exp Pathol (2014) 0.80
The tyrosine phosphatase SHP-1 negatively regulates cytotrophoblast proliferation in first-trimester human placenta by modulating EGFR activation. Cell Mol Life Sci (2012) 0.80
Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin. Sci Rep (2015) 0.79
The role of insulin-like growth factor-I in the physiopathology of hearing. Front Mol Neurosci (2011) 0.79
Will targeting insulin growth factor help us or hurt us?: An oncologist's perspective. Ageing Res Rev (2009) 0.79
Discovery of an Orally Efficacious Imidazo[5,1-f][1,2,4]triazine Dual Inhibitor of IGF-1R and IR. ACS Med Chem Lett (2010) 0.79
Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis. Oncotarget (2016) 0.78
IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptides. Oncoimmunology (2014) 0.78
Systematic evaluation of the metabolic to mitogenic potency ratio for B10-substituted insulin analogues. PLoS One (2012) 0.78
Effects of somatic mutations in the C-terminus of insulin-like growth factor 1 receptor on activity and signaling. J Signal Transduct (2012) 0.78
Sensory systems: their impact on C. elegans survival. Neuroscience (2014) 0.78
IGF-IR in patients with advanced colorectal cancer in correlation with certain clinico-morphological factors: Initial report. Oncol Lett (2011) 0.78
Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC). Vaccines (Basel) (2015) 0.78
Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy. Oncotarget (2016) 0.77
Theoretical and computational studies of peptides and receptors of the insulin family. Membranes (Basel) (2015) 0.77
Optimizing IGF-I for skeletal muscle therapeutics. Growth Horm IGF Res (2014) 0.77
The Roles of Insulin-Like Growth Factors in Mesenchymal Stem Cell Niche. Stem Cells Int (2017) 0.76
The IGF-1 receptor and regulation of nitric oxide bioavailability and insulin signalling in the endothelium. Pflugers Arch (2013) 0.76
Association of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 with the risk of ovarian cancer: A systematic review and meta-analysis. Mol Clin Oncol (2015) 0.76
Genetic Defects in the Growth Hormone-IGF-I Axis Causing Growth Hormone Insensitivity and Impaired Linear Growth. Front Endocrinol (Lausanne) (2011) 0.76
IGF-1R contributes to stress-induced hepatocellular damage in experimental cholestasis. Am J Pathol (2009) 0.76
Insulin-like growth factor and epidermal growth factor signaling in breast cancer cell growth: focus on endocrine resistant disease. Anal Cell Pathol (Amst) (2015) 0.76
The Insulin-Like Growth Factor System in the Long-Lived Naked Mole-Rat. PLoS One (2015) 0.76
Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature (1990) 4.70
Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature (1992) 3.82
Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies. Virology (1979) 2.66
Amino acid sequence changes in the haemagglutinin of A/Hong Kong (H3N2) influenza virus during the period 1968--77. Nature (1980) 2.23
A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature (1990) 2.17
The crystal structure of pneumococcal surface antigen PsaA reveals a metal-binding site and a novel structure for a putative ABC-type binding protein. Structure (1998) 1.96
Characterization of Munc-18c and syntaxin-4 in 3T3-L1 adipocytes. Putative role in insulin-dependent movement of GLUT-4. J Biol Chem (1997) 1.82
Structure of the influenza virus hemagglutinin. Curr Top Microbiol Immunol (1981) 1.80
Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature (1998) 1.79
Time course of individual Ca2+ sparks in frog skeletal muscle recorded at high time resolution. J Gen Physiol (1999) 1.79
E-C coupling failure in mouse EDL muscle after in vivo eccentric contractions. J Appl Physiol (1985) (1998) 1.62
Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase. Protein Sci (1995) 1.61
Structural homologies between RNA gene segments 10 and 11 from UK bovine, simian SA11, and human Wa rotaviruses. Virology (1985) 1.52
Structure and diversity of influenza virus neuraminidase. Curr Top Microbiol Immunol (1985) 1.48
Monoclonal antibodies and synthetic peptides define the active site of FcepsilonRI and a potential receptor antagonist. Allergy (2000) 1.45
Effects of imperatoxin A on local sarcoplasmic reticulum Ca(2+) release in frog skeletal muscle. Biophys J (2000) 1.38
Three-dimensional structures of two plant beta-glucan endohydrolases with distinct substrate specificities. Proc Natl Acad Sci U S A (1994) 1.36
Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nat Struct Biol (1999) 1.29
Structure of potyvirus coat proteins and its application in the taxonomy of the potyvirus group. Adv Virus Res (1989) 1.26
Antigenic determinants of influenza virus hemagglutinin. II. Antigenic reactivity of the isolated N-terminal cyanogen bromide peptide of A/Memphis/72 hemagglutinin heavy chain. Virology (1979) 1.23
Completion of the amino acid sequence of a Hong Kong influenza hemagglutinin heavy chain: sequence of cyanogen bromide fragment CN1. Virology (1980) 1.21
Evolution of the Hong Kong influenza A sub-type. Structural relationships between the haemagglutinin from A/duck/Ukraine/1/63 (Hav 7) and the Hong Kong (H3) haemagglutinins. Biochem J (1981) 1.20
Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain. Biochemistry (2001) 1.19
Influenza virus haemagglutinin. Structural predictions suggest that the fibrillar appearance is due to the presence of a coiled-coil. Aust J Biol Sci (1980) 1.19
Size and chemical composition of influenza virus hemagglutinin chains. FEBS Lett (1976) 1.18
Two mechanisms for termination of individual Ca2+ sparks in skeletal muscle. Proc Natl Acad Sci U S A (2000) 1.15
The crystal structure of poplar apoplastocyanin at 1.8-A resolution. The geometry of the copper-binding site is created by the polypeptide. J Biol Chem (1984) 1.08
Amino acid sequence and oligosaccharide distribution of the haemagglutinin from an early Hong Kong influenza virus variant A/Aichi/2/68 (X-31). Biochem J (1981) 1.04
Nucleotide sequence of gene segment 9 encoding a nonstructural protein of UK bovine rotavirus. Virology (1984) 1.03
The mechanism of antigenic drift in influenza virus: sequence changes in the haemagglutinin of variants selected with monoclonal hybridoma antibodies. Philos Trans R Soc Lond B Biol Sci (1980) 1.02
The disulfide bonds in the C-terminal domains of the human insulin receptor ectodomain. J Biol Chem (1997) 1.02
Site-directed mutagenesis of a potyvirus coat protein and its assembly in Escherichia coli. J Gen Virol (1993) 1.01
Antigenic determinants of influenza virus hemagglutinin. III. Competitive binding of antibodies directed against "common" and "strain-specific" antigenic determinants of A/Memphis/72 hemagglutinin. J Immunol (1979) 1.01
Primary structure of the Hong Kong (H3) haemagglutinin. Br Med Bull (1979) 0.98
Chemical and antigenic characterization of the carbohydrate side chains of an Asian (N2) influenza virus neuraminidase. Virology (1983) 0.97
The disulphide bonds of an Asian influenza virus neuraminidase. FEBS Lett (1983) 0.97
Insulin-responsive tissues contain the core complex protein SNAP-25 (synaptosomal-associated protein 25) A and B isoforms in addition to syntaxin 4 and synaptobrevins 1 and 2. Biochem J (1996) 0.97
Ageing, but not yet senescent, rats exhibit reduced muscle quality and sarcoplasmic reticulum function. Acta Physiol (Oxf) (2010) 0.96
A Hong Kong influenza hemagglutinin light chain: amino acid sequence of cyanogen bromide fragment CN2. Virology (1979) 0.95
Functional studies in 3T3L1 cells support a role for SNARE proteins in insulin stimulation of GLUT4 translocation. Biochem J (1997) 0.95
Neuraminidase gene from the early Asian strain of human influenza virus, A/RI/5-/57 (H2N2). Nucleic Acids Res (1982) 0.95
Carbohydrate composition of the oligosaccharide units of the haemagglutinin from the Hong Kong influenza virus A/Memphis/102/72. Biochem J (1980) 0.94
Antigenic determinants of influenza virus hemagglutinin. VII. The carbohydrate side chains of A/Memphis/102/72 hemagglutinin heavy chain which cross-react with host antigen. Virology (1981) 0.94
The carboxyl-terminal sequence of the heavy chain of a Hong Kong influenza haemagglutinin. Eur J Biochem (1978) 0.93
Purification and properties of insulin receptor ectodomain from large-scale mammalian cell culture. Protein Expr Purif (1995) 0.93
Congenital insulin resistance associated with a conformational alteration in a conserved beta-sheet in the insulin receptor L1 domain. J Biol Chem (1999) 0.92
Amino acid sequence of the Pronase-released heads of neuraminidase subtype N2 from the Asian strain A/Tokyo/3/67 of influenza virus. Biochem J (1982) 0.92
Localization of virus-specific and group-specific epitopes of plant potyviruses by systematic immunochemical analysis of overlapping peptide fragments. Proc Natl Acad Sci U S A (1989) 0.92
Positioning of a peptide in the cleft of HLA-A2 by complementing amino acid changes. Proc Natl Acad Sci U S A (1991) 0.92
The use of 3' non-coding nucleotide sequences in the taxonomy of potyviruses: application to watermelon mosaic virus 2 and soybean mosaic virus-N. J Gen Virol (1989) 0.92
Antigenic determinants of influenza virus hemagglutinin. I. Cyanogen bromide peptides derived from A/MEMPHIS/72 hemagglutinin possess antigenic activity. Virology (1978) 0.92
The three dimensional structure of the type I insulin-like growth factor receptor. Mol Pathol (2001) 0.92
Antigenic determinants of influenza virus hemagglutinin--IX. The carbohydrate side chains from an Asian strain. Mol Immunol (1982) 0.92
Chimeric potyvirus-like particles as vaccine carriers. Intervirology (1996) 0.91
Antigenic determinants of influenza virus hemagglutinin. IV. Immunogenicity of fragments isolated from the hemagglutinin of A/Memphis/72. J Immunol (1979) 0.90
Substrate, inhibitor, or antibody stabilizes the Glu 119 Gly mutant influenza virus neuraminidase. Virology (1998) 0.89
Expression of potyvirus coat protein in Escherichia coli and yeast and its assembly into virus-like particles. J Gen Virol (1991) 0.89
Effects of lactate on force production by mouse EDL muscle: implications for the development of fatigue. Can J Physiol Pharmacol (1998) 0.89
Enzymes of beta-oxidation and their function during development of Ascaris lumbricoides eggs. Dev Biol (1970) 0.89
Molecular cloning and analysis of the N5 neuraminidase subtype from an avian influenza virus. Virology (1989) 0.89
High affinity insulin binding by soluble insulin receptor extracellular domain fused to a leucine zipper. FEBS Lett (2000) 0.89
Coat protein of potyviruses. 4. Comparison of biological properties, serological relationships, and coat protein amino acid sequences of four strains of potato virus Y. Arch Virol (1988) 0.88
Identification and classification of potyviruses on the basis of coat protein sequence data and serology. Brief review. Arch Virol (1989) 0.87
Biochemical analysis and crystallisation of Fc gamma RIIa, the low affinity receptor for IgG. Immunol Lett (1999) 0.87
Decreased contraction economy in mouse EDL muscle injured by eccentric contractions. J Appl Physiol (1985) (1996) 0.87
The relationship between the L1 and L2 domains of the insulin and epidermal growth factor receptors and leucine-rich repeat modules. BMC Bioinformatics (2001) 0.86
Novel isoform of syntaxin 1 is expressed in mammalian cells. Biochem J (1997) 0.86
High level production of hybrid potyvirus-like particles carrying repetitive copies of foreign antigens in Escherichia coli. Biotechnology (N Y) (1993) 0.86
The location of the bromelain cleavage site in a Hong Kong influenza virus Haemagglutinin. J Gen Virol (1981) 0.86
Mutational analysis of the N-linked glycosylation sites of the human insulin receptor. Biochem J (2000) 0.85
The amino acid sequence of a Hong Kong influenza haemagglutinin light (HA2) chain. J Gen Virol (1980) 0.85
Evaluation of complete genome sequences and sequences of individual gene products for the classification of hepatitis C viruses. Arch Virol (1995) 0.85
Physicochemical and immunological characterization of recombinant host-protective antigen (VP2) of infectious bursal disease virus. Vaccine (1991) 0.84
Crystallization of the first three domains of the human insulin-like growth factor-1 receptor. Protein Sci (1997) 0.83
Aryl acylamidase activity in larvae of the webbing clothes moth, Tineola bisselliella. Comp Biochem Physiol B (1976) 0.83
Antigenic determinants of influenza virus hemagglutinin. V. Antigenicity of the HA2 chain. J Immunol (1980) 0.83
Spectral data for modified assay of benzoyl-arginine p-nitroanilide-hydrolysing enzymes in crude extracts. Anal Biochem (1973) 0.82
Molecular cloning of cDNAs encoding (1-->4)-beta-xylan endohydrolases from the aleurone layer of germinated barley (Hordeum vulgare). Plant Mol Biol (1996) 0.82
Properties of an insulin receptor with an IGF-1 receptor loop exchange in the cysteine-rich region. FEBS Lett (2000) 0.82
Coat protein of potyviruses. 5. Symptomatology, serology, and coat protein sequences of three strains of passionfruit woodiness virus. Arch Virol (1988) 0.82
Botulinum E toxin light chain does not cleave SNAP-23 and only partially impairs insulin stimulation of GLUT4 translocation in 3T3-L1 cells. Biochem Biophys Res Commun (1997) 0.81
A Hong Kong influenza hemagglutinin light chain: the amino acid sequence of cyanogen bromide fragments CN3 and CN4 and the N-terminal 45 residues. Virology (1979) 0.81
Single-molecule imaging of human insulin receptor ectodomain and its Fab complexes. J Struct Biol (1999) 0.81
Sequence diversity in the surface-exposed amino-terminal region of the coat proteins of seven strains of sugarcane mosaic virus correlates with their host range. Arch Virol (1993) 0.81
The isolation, characterization and cloning of a globin-like, host-protective antigen from the excretory-secretory products of Trichostrongylus colubriformis. Mol Biochem Parasitol (1992) 0.81
Fatigue-induced alterations in Ca2+ and caffeine sensitivities of skinned muscle fibers. J Appl Physiol (1985) (1993) 0.80
Passive protection against infectious bursal disease virus by viral VP2 expressed in yeast. Vaccine (1990) 0.80
Cysteine-524 is not the only residue involved in the formation of disulphide-bonded dimers of the insulin receptor. Biochem J (1994) 0.80
Amino acid sequence of cyanogen bromide fragment CN2 from Hong Kong influenza haemagglutinin heavy chain. Aust J Biol Sci (1980) 0.80
Comparison of orthorhombic and monoclinic crystal structures of HLA-A2. Cold Spring Harb Symp Quant Biol (1989) 0.80
Polysaccharide hydrolases in germinated barley and their role in the depolymerization of plant and fungal cell walls. Int J Biol Macromol (1997) 0.80
Modelling and predicting the biological effects of nanomaterials. SAR QSAR Environ Res (2014) 0.80
Subsite affinities and disposition of catalytic amino acids in the substrate-binding region of barley 1,3-beta-glucanases. Implications in plant-pathogen interactions. J Biol Chem (1995) 0.80
A tetrad of ionizable amino acids is important for catalysis in barley beta-glucanases. J Biol Chem (1995) 0.79
Pilins from the B serogroup of Bacteroides nodosus: characterization, expression, and cross-protection. Infect Immun (1990) 0.79
Carbon dioxide fixation and phosphoenolpyruvate metabolism in Trichinella spiralis larvae. J Parasitol (1969) 0.79